Director Schlichting Nancy M sold 7,050 shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) for $5,709 in transaction occurred on 2018/11/20. After making this transaction, the Director owns a direct stake of 555,611 shares, worth $408,536, as per the last closing price. On 2018/11/01 Scardino Kimberly R, SVP, Global Controller and CAO at WBA, dumped 11,970 shares at an average price of $79.79 per share. The selling total is valued at $.

Separately, it had been reported that some other WBA insiders also took part of the insider trading activity. Director, Foote William C had divested 2,736 shares for $8,207 through a trade on 2018/11/01. Following this activity, the insider holds 217,457 shares worth $587,293 as of recent close. Wall Street’s most bullish Walgreens Boots Alliance, Inc. (NASDAQ:WBA) analysts are predicting the share price to blow past $95 per share during the next 12 months. The current median share price forecast by them is $75, suggesting that the stock could increase 4.81% in that time frame. The average price target of $76.17 calls for a nearly 6.44% increase in the stock price.

Walgreens Boots Alliance, Inc. (WBA) trading activity significantly weakened as the volume at ready counter decreased to 3,970,062 shares versus 4,705,210 in average daily trading volume over the past 20 days. So far this year, the volume has averaged about 5,111,207 shares. The share price rose 1.55% in recent trade and currently has a stock-market value of $68.55B. The shares finished at $71.56, after trading as low as $70.7 earlier in the session. It hit an intraday high Tuesday at $71.98. The stock is now 21.14% above against its bear-market low of $59.07 on June 28, 2018. It has retreated -20.61% since it’s 52-week high of $86.31 reached in December. Now the market price is up 4.53% on the year and up 4.73% YTD.

WBA’s 50 day simple moving average (SMA 50) price is $73.45 and its 200-day simple moving average (SMA 200) price is $70.6. The company’s stock currently has a total float of 795.81M shares. Its weekly volatility is hovering around 1.42% and felt 1.43% volatility in price over a month. On the upside, the share price will test short term resistance at around $72.13. On a downside, the stock is likely to find some support, which begins at $70.85. The failure to get near-term support could push it to $70.13.

It had seen a new analyst call from UBS, which initiated the stock at Sell on January 17. Analysts at Wolfe Research, started covering the stock on December 19 with a Peer Perform rating. The stock lost favor of Goldman analysts who expressed their lack of confidence in it using a downgrade from Neutral to Sell on December 14.

When looking at valuations, Walgreens Boots Alliance, Inc. (WBA) has a cheap P/E of 13.5x as compared to industry average of 17.89x. Moreover, it trades for 10.15 times the next 12 months of expected earnings. Also, it is trading at rather expensive levels at just over 2.65x price/book and 0.51x price/sales. Compared to others, Walgreens Boots Alliance, Inc. is in a different league with regards to profitability, having net margins of 4%. To put some perspective around this, the industry’s average net margin is 2.21%. WBA’s ROE is 20%, which is also considerably better than the industry’s ROE of 11.69%. It’s also not liquid in the near term, with a current ratio of 0.8. The stock has a debt/capital of 0.62.

Shares of Walgreens Boots Alliance, Inc. (WBA) have dropped -3.8% since the company’s last earnings report. Over the past 12 fiscal quarters, Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has topped consensus earnings estimates in 11 quarters (91%), missed earnings in 0 quarters (0%), whereas at 1 occasion EPS met analyst expectations. WBA last reported earnings on December 20, 2018 when it released Nov-18 results that exceeded expectations. The company raked in $1.46 per share, -22.75% change on the same period last year. That was better than consensus for $1.43. Revenue for the recent quarter stood at $33.79 billion, up 10% on last year and below the $33.78 billion predicted by analysts. For this quarter, Wall Street analysts forecast revenue in a range of $33.91 billion to $35.39 billion, which should be compared with $35.09 billion generated last year. EPS is seen in a range of $1.35 to $1.66, against the $1.61 reported a year ago.